Afp and Hcg in Germ Cell Tumors
Abstract
The high specificity and sensitivity of testicular tumor markers make them particularly useful in the management of these neoplasms. Basal value represents an independent prognostic variable, influencing the choice of therapy. An increase in marker level before chemotherapy could also acquire a powerful prognostic significance. The decay curve pattern is indicative of the radicality of surgery. Also during chemotherapy the behavior of markers conditions further therapeutic strategies.
Get full access to this article
View all access and purchase options for this article.
References
1. Bagshaw K.D., Begent R.H.J. Staging, markers and prognostic factors. Clin in Oncol 1983; 2: 159–81.
2. Fossa A., Fossa S.D. Serum lactate dehydrogenase and human choriogonadotrophin in seminoma. Br J Urol 1989; 63: 408–15.
3. Lange P.H., Winfield H.N. Biological markers in urologic cancer. Cancer 1987; 60: 464–72.
4. Bombardieri E., Pizzocaro G., Seregni E., Castellani M.R., Cozzi A., Buraggi G.L. I marcatori circolanti dei tumori germinali del testicolo. In: Veronesi U., Pizzocaro G., Pisani E., Santoro A., eds. I tumori genito-urinari. Milano: Casa Editrice Ambrosiana, 1989; 263–74.
5. Vogelzang N.J. Prognostic factors in metastatic testicular cancer. Int J Androl 1987; 10: 225–37.
6. Salvioni R., Zanoni F., Milani A., Piva L., Aguzzi L., Pizzocaro G. Classificazione in stadi dei tumori germinali del testicolo. In: Veronesi U., Pizzocaro G., Pisani E., Santoro A., eds. I tumori genito-urinari. Milano: Casa Editrice Ambrosiana, 1989; 283–6.
7. Price P., Hogan S.G., Horwich A. The growth rate of metastatic non-seminomatus germ cell testicular tumours measured by marker production doubling time - I. Theoretical basis and practical application. Eur J Cancer 1990; 26: 450–3.
8. Price P., Hogan S., Horwich A. The growth rate of metastatic non-seminomatous germ cell testicular tumours measured by marker production doubling time - II. Prognostic significance in patients treated by chemotherapy. Eur J Cancer 1990; 26: 453–7.
9. Horwich A., Peckham M.J. Serum tumor marker regression ratio following chemotherapy for malignant teratoma. Eur J Cancer Clin Oncol 1984; 20: 1463–70.
10. Picozzi V.J. Jr., Freiha F.S., Hannigan J.F. Jr., Torti F.M. Prognostic significance of a decline in serum human chorionic gonadotropin levels after initial chemotherapy for advanced germ-cell. Ann Int Med 1984; 100: 183–6.
11. Toner G.C., Geller N.L., Tan C., Bosl G.J. Serum tumor marker half-life during chemotherapy (CT) allows early prediction of complete response (CR) and survival in non-seminomatous germ cell tumors (NSGCT). Proc Am Soc Clin Oncol ASCO 1990; 9: 133 (abs. 514).
12. Toner G.C., Geller N.L., Tan C., Nisselbaum J., Bosl G.J. Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumors. Cancer Res 1990; 50: 5904–10.
13. Hoskin P., Dilly S., Easton D., Horwich A., Hendry W., Peckham M.J. Prognostic factors in stage I non-seminomatous germ-cell testicular tumors managed by orchiectomy and surveillance: implications for adjuvant chemotherapy. J Clin Oncol 1986; 4: 1031–6.
14. Williams S.D., Stablein D.N., Einhorn L.H.et al. Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. N Engl J Med 1987; 317: 1433–8.
15. Vugrin D., Friedman A., Whitmore W.F. Correlation of serum tumor markers in advanced germ cell tumors with responses to chemotherapy and surgery. Cancer 1984; 53: 1440–5.
Cite article
Cite article
Cite article
OR
Download to reference manager
If you have citation software installed, you can download article citation data to the citation manager of your choice
Information, rights and permissions
Information
Published In
Article first published: January/March 1994
Issue published: January/March 1994
Keywords
PubMed: 7519651
Authors
Metrics and citations
Metrics
Journals metrics
This article was published in The International Journal of Biological Markers.
VIEW ALL JOURNAL METRICSArticle usage*
Total views and downloads: 5
*Article usage tracking started in December 2016
Articles citing this one
Receive email alerts when this article is cited
Web of Science: 0
Crossref: 6
-
RETRACTED: Fetus-in-fetu in Botswana
-
Serum nucleosomes during neoadjuvant chemotherapy in patients with cer...
-
Fetus in fetu—diagnostic criteria and differential diagnosis—a case re...
-
Serum Tumor Marker Test Profile in Testicular Germ-Cell Tumors
-
Fetus-in-fetu with malignant recurrence
-
The serum level of markers during chemotherapy as prognostic indicator...
Figures and tables
Figures & Media
Tables
View Options
Get access
Access options
If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below:
loading institutional access options
Alternatively, view purchase options below:
Purchase 24 hour online access to view and download content.
Access journal content via a DeepDyve subscription or find out more about this option.
